INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
105 hedge funds and large institutions have $145M invested in Inozyme Pharma in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+16
Holders Change %
+17.98%
% of All Funds
1.4%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
35
Increased
34
Reduced
17
Closed
19
Calls
$7K
Puts
$15K
Net Calls
-$8K
Net Calls Change
+$6K
Top Buyers
| 1 |
AAA
1
Affinity Asset Advisors
New York
|
$11M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$1.71M |
| 3 |
3
BlackRock
New York
|
$10.6M |
| 4 |
4
Renaissance Technologies
New York
|
$1.17M |
| 5 |
5
Walleye Capital
New York
|
$658K |
